Treatment of Melioidosis

Ella M. Meumann; Giri Rajahram; Stephen D. Woolley; Simon Smith; Ian Gassiep

doi:10.1016/j.idc.2025.12.002

Treatment of Melioidosis

Ella M. Meumann
, Giri Rajahram
, Stephen D. Woolley
, Simon Smith
, Ian Gassiep

Clinical Sciences

Royal Darwin Hospital
Territory Pathology
Charles Darwin University
Queen Elizabeth II Hospital
Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit
Monash University Malaysia
University Hospital of Liverpool Group
Queensland Health
University of Queensland
Mater Group
Royal Brisbane and Women's Hospital

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Melioidosis is caused by the gram-negative bacterium, Burkholderia pseudomallei, a soil and water saprophyte endemic to tropical and subtropical regions globally. Infection occurs following percutaneous inoculation following (sometimes minor) trauma, inhalation/aspiration, or ingestion of unchlorinated water; person-to-person and zoonotic infection are extremely rare. Clusters of cases due to a common source occasionally occur due to contaminated products

Original language	English
Pages (from-to)	127-147
Number of pages	21
Journal	Infectious Disease Clinics of North America
Volume	40
Issue number	1
Early online date	21 Jan 2026
DOIs	https://doi.org/10.1016/j.idc.2025.12.002
Publication status	Published - 1 Mar 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antimicrobial resistance
Burkholderia pseudomallei
Melioidosis
Treatment

Access to Document

10.1016/j.idc.2025.12.002Licence: CC BY

1-s2.0-S0891552025001072-mainFinal published version, 1.95 MBLicence: CC BY

Cite this

@article{0f601ad934a2423792ddaf426ed50b4d,

title = "Treatment of Melioidosis",

abstract = "Melioidosis is caused by the gram-negative bacterium, Burkholderia pseudomallei, a soil and water saprophyte endemic to tropical and subtropical regions globally. Infection occurs following percutaneous inoculation following (sometimes minor) trauma, inhalation/aspiration, or ingestion of unchlorinated water; person-to-person and zoonotic infection are extremely rare. Clusters of cases due to a common source occasionally occur due to contaminated products",

keywords = "Antimicrobial resistance, Burkholderia pseudomallei, Melioidosis, Treatment",

author = "Meumann, \{Ella M.\} and Giri Rajahram and Woolley, \{Stephen D.\} and Simon Smith and Ian Gassiep",

year = "2026",

month = mar,

day = "1",

doi = "10.1016/j.idc.2025.12.002",

language = "English",

volume = "40",

pages = "127--147",

journal = "Infectious Disease Clinics of North America",

issn = "0891-5520",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Treatment of Melioidosis

AU - Meumann, Ella M.

AU - Rajahram, Giri

AU - Woolley, Stephen D.

AU - Smith, Simon

AU - Gassiep, Ian

PY - 2026/3/1

Y1 - 2026/3/1

N2 - Melioidosis is caused by the gram-negative bacterium, Burkholderia pseudomallei, a soil and water saprophyte endemic to tropical and subtropical regions globally. Infection occurs following percutaneous inoculation following (sometimes minor) trauma, inhalation/aspiration, or ingestion of unchlorinated water; person-to-person and zoonotic infection are extremely rare. Clusters of cases due to a common source occasionally occur due to contaminated products

AB - Melioidosis is caused by the gram-negative bacterium, Burkholderia pseudomallei, a soil and water saprophyte endemic to tropical and subtropical regions globally. Infection occurs following percutaneous inoculation following (sometimes minor) trauma, inhalation/aspiration, or ingestion of unchlorinated water; person-to-person and zoonotic infection are extremely rare. Clusters of cases due to a common source occasionally occur due to contaminated products

KW - Antimicrobial resistance

KW - Burkholderia pseudomallei

KW - Melioidosis

KW - Treatment

U2 - 10.1016/j.idc.2025.12.002

DO - 10.1016/j.idc.2025.12.002

M3 - Article

AN - SCOPUS:105028177494

SN - 0891-5520

VL - 40

SP - 127

EP - 147

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

IS - 1

ER -

Treatment of Melioidosis

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this